<p>Pliant Therapeutics Inc. has announced that Chief Medical Officer Éric Lefebvre, M.D., will be leaving the company effective December 15, 2025. Dr. Lefebvre is expected to continue assisting the company as a consultant to support the transition of his responsibilities. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001746473-25-000179), on December 08, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

PLRX

<p>Pliant Therapeutics Inc. announced the departure of Chief Medical Officer Éric Lefebvre, M.D., effective December 15, 2025. Dr. Lefebvre will continue as a consultant to assist with the transition of his responsibilities.</p>

Pliant Therapeutics Announces Departure of Chief Medical Officer Éric Lefebvre